E

EZZ Life Science Holdings Ltd
ASX:EZZ

Watchlist Manager
EZZ Life Science Holdings Ltd
ASX:EZZ
Watchlist
Price: 0.64 AUD -9.22% Market Closed
Market Cap: AU$30.1m

EZZ Life Science Holdings Ltd
PP&E Gross

Last Value
3 Years CAGR 3Y CAGR
5 Years CAGR 5Y CAGR
10 Years CAGR 10Y CAGR
Last Value
3 Years CAGR 3Y CAGR
5 Years CAGR 5Y CAGR
10 Years CAGR 10Y CAGR
Quarterly
Annual
|
See Also

EZZ Life Science Holdings Ltd
PP&E Gross Peer Comparison

EZZ Life Science Holdings Ltd
Glance View

EZZ Life Science Holdings Ltd. engages in wholesale distributor of skin care products under the EAORON brand to pharmacies, supermarkets and specialist retailers. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm is wholesale distributor of EAORON skin care products for the Australian and New Zealand markets. The company develops, manufactures and distributes genetic technology enabled consumer health products under its own brand, EZZ. The EAORON brand comprises of five product lines, including Hyaluronic Series, Facial Mask Series, Crystal White Series, Specific Care Series and Anti-Sugar Series. The EZZ products cover market segments, including vitamin and dietary supplements, sports nutrition, wright management and wellbeing, herbal/ traditional and pediatric consumer health products.

EZZ Intrinsic Value
4.25 AUD
Undervaluation 85%
Intrinsic Value
Price AU$0.64
E

See Also

What is EZZ Life Science Holdings Ltd's PP&E Gross?
PP&E Gross
890.1k AUD

Based on the financial report for Jun 30, 2025, EZZ Life Science Holdings Ltd's PP&E Gross amounts to 890.1k AUD.

What is EZZ Life Science Holdings Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
56%

Over the last year, the PP&E Gross growth was 43%. The average annual PP&E Gross growth rates for EZZ Life Science Holdings Ltd have been 82% over the past three years , 56% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett